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Abstract Purpose To evaluate the effectiveness of a
workplace integrated care intervention on at-work pro-
ductivity loss in workers with rheumatoid arthritis (RA)
compared to usual care. Methods In this randomized con-
trolled trial, 150 workers with RA were randomized into
either the intervention or control group. The intervention
group received an integrated care and participatory work-
place intervention. Outcome measures were the Work
Limitations Questionnaire, Work Instability Scale for RA,
pain, fatigue and quality of life (RAND 36). Participants
filled out a questionnaire at baseline, and after 6 and
12 months. We performed linear mixed models to analyse
the outcomes. Results Participants were on average
50 years of age, and mostly female. After 12 months, no
significant intervention effect was found on at-work pro-
ductivity loss. We also found no significant intervention
effects on any of the secondary outcomes. Conclusions We
did not find evidence for the effectiveness of our workplace
integrated care intervention after 12 months of follow up.
Future studies should focus on investigating the interven-
tion in groups of workers with severe limitations in work
functioning, and an unstable work situation.
Keywords Rheumatoid arthritis  Work  Randomized
controlled trial  Workplace intervention
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disease
which is characterized by inflamed joints. Despite treat-
ment of RA with conventional disease modifying anti-
rheumatic drugs, or more recently, with biological thera-
peutics, RA still leads to profound symptoms [1]. These
symptoms, such as stiffness of the joints, pain and fatigue,
might fluctuate.
RA also impacts a person’s working life [2]. Many
studies have shown that permanent work disability occurs
more frequently in patients with RA when compared to the
general population, although there is a slight decrease in
work disability rates during recent years [3–6]. For exam-
ple in the study of Sokka et al. [3], it was shown that the
probabilities for continuing work were 80 % after 2 years,
and 68 % after 5 years for workers with RA. Before a
patient becomes permanently work disabled, he goes
through a process in which continuing work becomes more
and more difficult. At first, patients might experience at-
work productivity loss. This means that a patient is still
present at work, but is limited in meeting work demands,
& C. R. L. Boot
crl.boot@vumc.nl
1 Department of Public and Occupational Health, EMGO
Institute for Health and Care Research, VU University
Medical Center, Room BS7-C573, Van der Boechorststraat 7,
1081 BT Amsterdam, The Netherlands
2 Body@Work, Research Center on Physical Activity, Work,
and Health, TNO-VU University Medical Center,
Amsterdam, The Netherlands
3 Department of Health Sciences Section Methodology and
Applied Biostatistics, VU University, Amsterdam,
The Netherlands
4 TNO Work, Health and Care, Leiden, The Netherlands
5 Department of Rheumatology, VU University Medical
Center, Amsterdam, The Netherlands
6 Jan van Breemen Research Institute | Reade, Amsterdam,
The Netherlands
7 Research Center for Insurance Medicine, AMC-UMCG-
UWV-VU University Medical Center, Amsterdam,
The Netherlands
123
J Occup Rehabil (2017) 27:128–136
DOI 10.1007/s10926-016-9639-0
and is therefore less productive at work. If work func-
tioning becomes very difficult, a patient might call in sick.
Sick leave can lead to permanent work disability, or
patients can return to work. The longer the period of sick
leave, the harder it is to return to work [7]. For this reason,
to prevent patients with RA becoming permanently work
disabled, interventions should focus on patients in an early
stage, preferably patients who are not yet sick-listed.
Patients with RA experience reduced health related
quality of life compared to the general population [8],
which might be even more reduced in case of work dis-
ability. Previous studies showed that reduced work capac-
ity not only leads to financial restrains, but is also related to
reduced quality of life [9, 10]. Patients with RA who are
restricted in work might furthermore experience feelings of
hopelessness, sadness, anger and irritation [11].
In order to support workers with RA in maintaining and
improving productivity at work, the Care for Work project
was initiated. In this project, an intervention program,
consisting of integrated care and a participatory workplace
intervention, was evaluated in a group of workers with RA.
The aim of this study was to evaluate the effectiveness of
the intervention program on at-work productivity loss, pain,
fatigue and quality of life compared to usual care, after
12 months of follow-up. We hypothesize that the interven-
tion program leads to a reduction in at-work productivity
loss, improved quality of life, and less pain and fatigue.
Materials and Methods
Design
The effectiveness of the Care for Work intervention pro-
gram was evaluated using a randomized controlled trial
(RCT). Participants who gave written informed consent
took part in three measurements. One before the start of the
intervention, baseline (T0), after 6 (T1) and after
12 months (T2). The study design and procedures were
approved by the Medical Ethics Committee of the Sloter-
vaart hospital and Reade, and the Medical Ethics Com-
mittee of the VU University Medical Center. This trial was
registered in the Dutch Trial Register (NTR2886). Details
of the trial have been described elsewhere [12].
Participants
Participants were recruited at Reade, Amsterdam, the out-
posts of Reade, and the department of rheumatology of the
VU University Medical Center, Amsterdam. Eligible
patients were 18–64 years of age, diagnosed with RA, had
a paid job for at least 8 h per week (employment contract
or self-employed), and experienced at least minor
difficulties in functioning at work. Patients could not par-
ticipate in case of severe comorbidity, inability to read or
understand Dutch language, and in case of more than
3 months of sick leave duration at time of inclusion. Eli-
gible patients received an information letter about the
project from their own rheumatologist.
Randomization and Blinding
After baseline measurements, participants were individu-
ally randomized into either the intervention group or con-
trol group (usual care). Participants were pre-stratified by
three prognostic factors; sex, number of work hours per
week (\20 h and[20 h per week), and whether a partic-
ipant performed heavy or light physically/mentally
demanding work, based on the classification of De Zwart
[13]. Randomization occurred with the minimization
method, by applying a software program called Minim
[14], which allows pre-stratification by several prognostic
factors even in small samples [15, 16]. Due to the character
of the intervention, participants, therapists and researchers
could not be blinded for the allocated treatment.
Intervention
All patients received usual rheumatologist-led care. The
patients in the intervention program also received the Care
for Work intervention program [12]. The program con-
sisted of two components which complemented each other;
integrated care and a participatory workplace intervention.
Integrated care was delivered by a multidisciplinary team,
which consisted of a trained clinical occupational physician
(who acted as care manager), a trained occupational ther-
apist, and the patients’ own rheumatologist. The care
manager coordinated care and communicated with mem-
bers of the multidisciplinary team, the patient’s supervisor,
occupational physician and general practitioner. The care
manager performed the intake of the patient in the inter-
vention, which consisted of history taking and physical
examination to identify functional limitations at work and
factors that could influence functioning at work. The care
manager proposed a treatment plan at the end of the first
consultation. After the patient’s consent, the care manager
sent the treatment plan to the other members of the mul-
tidisciplinary team. The patients visited the care manager
again after 6 and 12 weeks to evaluate. After the occupa-
tional therapist received the treatment plan from the care
manager, the occupational therapist started the participa-
tory workplace intervention, which is based on active
participation and strong commitment of both the patient
and supervisor. The workplace intervention was based on
participatory ergonomics [17–19]. The aim of the work-
place intervention was to achieve consensus between
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patient and supervisor regarding feasible solutions for
obstacles for functioning at work. After consensus, the
occupational therapist, patient and supervisor agreed on a
plan of action. The patient and supervisor were responsible
for implementing the plan of action. The occupational




At-work productivity loss was operationalized as hours lost
from work due to presenteeism. Presenteeism refers to
being present at work, but being limited in meeting work
demands, and hence, at-work productivity is reduced. We
measured at-work productivity loss with the Work Limi-
tations Questionnaire (WLQ). A score was calculated
based on 25 items which presents the percentage of at-work
productivity loss. This score was multiplied by the number
of working hours per 2 weeks, resulting in an estimation of
the hours of experienced at-work productivity loss during
the past 2 weeks. The WLQ consists of four subscales
(time management demands, physical demands, mental-
interpersonal demands, and output demands) which are
calculated into scores ranging from 0 (no limitations) to
100 (highest limitations). The internal reliability is high for
the separate WLQ subscales [20]. The good validity and
reliability of the WLQ concerning RA have been shown in
several previous studies [20–22].
Secondary Outcomes
Quality of Life We measured quality of life with the
RAND 36 [23, 24]. The RAND 36 consists of nine sub-
scales, we included four subscales in our analyses. These
subscales are mental health, physical role limitations,
physical functioning, and perceived health change. The
subscales of the RAND 36 are transformed into a scale
score ranging from 0 to 100. A higher score indicates better
health.
Pain and Fatigue Pain and fatigue were measured with
single items using visual analogue scales (VAS) [25, 26].
Studies have shown that a single item VAS for fatigue and
pain performs as well as or better than longer scales in
respect to sensitivity to change [26, 27]. We asked patients
to indicate their perceived pain/fatigue today. VAS scales
ranged from 0 to 10, with 0 meaning no pain/fatigue at all,
and 10 meaning a lot of pain/very tired.
Work Instability Work instability was measured with the
RA Work Instability Scale (RA WIS) [28, 29]. The RA
WIS contains 23 statements such as ‘I’m getting up earlier
because of the arthritis’. By counting the statements
answered by yes, the RA WIS score is calculated, leading
to a score between 0 and 23. A higher score indicates more
work instability.
Potential Confounders
At baseline, data on potential confounders were collected.
We collected age and gender from patient medical records.
Education level was measured using a single item in the
questionnaire. Low education was operationalized as pri-
mary school, middle education or basic vocational educa-
tion. Middle education was operationalized as secondary
vocational education or intermediate vocational education.
High education was operationalized as higher vocational
education or a university degree. Whether comorbidity was
present (yes/no) was assessed with a list of 15 common
comorbidities. The Disease Activity Score of 28 joints
(DAS28) was assessed as a part of usual care and was
collected from patient records. The DAS28 score was
based on the number of tender and swollen joints in 28
joints, the erythrocyte sedimentation rate (ESR) and the
patient’s general health measured on a VAS of 100 mm
[30]. We furthermore retrieved the prescription of biolog-
ical therapeutics from the patient medical records. Disease
duration was investigated by one open-ended question
about the year of the RA diagnosis. Daily functioning was
measured with the Health Assessment Questionnaire
(HAQ), a reliable and valid questionnaire [31]. We asked
participants whether they were satisfied with their job
(not/moderately satisfied or (very) satisfied). We measured
co-worker support, supervisor support, decision authority,
physical job demands and psychological job demands with
the Job Content Questionnaire (JCQ) [32]. We furthermore
included baseline data of all of the primary and secondary
outcomes described above as potential confounders.
Co-interventions were investigated by one item in the
questionnaire; we asked participants whether their work
situation was adapted during the past 6 months, indepen-
dent of the Care for Work project.
Sample Size
The sample size was calculated based on the number of
participants needed to identify an effect on at-work pro-
ductivity loss, which was measured with the WLQ. We
assumed that a difference of 2 h per 2 weeks was a relevant
difference. This is based on a study where an average of
four lost hours per 2 weeks (SD: 3.9) was found with the
WLQ [33]. A 2 h per 2 weeks difference implies a mod-
erate standardized effect of 0.5. Power analysis revealed a
sample size of 71 patients per group. Assuming a dropout
130 J Occup Rehabil (2017) 27:128–136
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rate of 15 %, 142 patients had to be included in total, with
a power of 0.80 and an alpha of 0.05.
Statistical Analyses
We performed linear mixed models with each outcome
measure as dependent variable. Intervention or control
group was the independent variable and all analyses were
adjusted for the baseline value of the outcome. Time of the
follow-up measurements was the fixed factor (T1:
6-months follow-up, T2: 12-months follow-up). Data were
analyzed according to the intention-to-treat principle,
indicating that all participants were analyzed according to
the condition they were allocated to, despite whether they
had engaged in the intervention. We performed crude and
adjusted analyses. To select potential confounders, we
checked baseline differences between the intervention and
control group, and selected those variables with a p value
\0.4. Secondly, we assessed correlations between the
remaining covariates and the outcome. If Pearson’s R was
higher than 0.7, the covariate with the weakest correlation
with the outcome was not included as confounder. The
remaining covariates were entered into the adjusted model.
We checked effect modification by co-interventions by
adding an interaction term to the adjusted model. p values
\0.05 were considered statistically significant. All analy-
ses were performed using SPSS software (version 20.0).
Results
In total, 1973RApatientswere invited to participate (Fig. 1).
Wedid not have information aboutwork status of the patients
that were invited by the rheumatologist. In total, 1531
patients did not return the reply card or indicated that they
were not interested, possibly because they did not have a paid
job. Eventually, 150 patients completed the baseline ques-
tionnaire and were randomized into either the control or
intervention group. After 6 months, 147 participants com-
pleted the first follow-up questionnaire, and after 12 months,
143 participants completed the second follow-up question-
naire. Loss to follow-up was therefore 4.7 %.
Table 1 presents the baseline characteristics of the study
population. Participants were on average 50 years of age,
and mostly female. Participants scored 0.8 on the HAQ, and
the DAS28 was on average 2.7. Almost half of our study
population had ever used biological therapeutics (45 % in
the control group and 48 % in the intervention group).
Due to a systematic error in our minimisation procedure,
a subgroup of 37 participants was considered at risk to be
mistakenly allocated to the control or intervention group.
For this reason we conducted a sensitivity analysis on the
subgroup in which we left out the 37 participants at risk, to
determine the impact of the potential bias on the study
results. In this subgroup, 55 patients were randomised into
the intervention group and 58 patients into the control
group. Before conducting the sensitivity analyses, a change
in the regression coefficients of[10 % between the two
analyses was defined as a relevant difference. All analyses
were replicated by an independent researcher.
Intervention Effects
Primary Outcome
At baseline, the intervention group lost on average 4.6 h
per 2 weeks due to at-work productivity loss. The control
group lost 3.4 h per 2 weeks. After 12 months, the inter-
vention group remained constant, while the control group
increased slightly over time with 0.1 h per 2 weeks. No
significant intervention effects were observed on at-work
productivity loss (the difference between the two groups on
average over time (B) was 0.24 (95 % CI -0.43 to 0.90).
We also did not find intervention effects on any of the four
subscales of the WLQ. No increase or decrease was
observed over time in any of the two groups (Table 2). The
use of co-interventions was not found to be a relevant
effect modifier in the analyses.
Secondary Outcomes
Table 2 shows the results of the mixed model analyses on
the secondary outcomes. We found no significant inter-
vention effects on the secondary outcomes. For work
instability, both groups remained fairly constant over time,
leading to a B of -0.29 (95 % CI -1.41 to 0.84). The
analyses on pain and fatigue did not show a considerable
effect of the intervention [B 0.19 (95 % CI -0.41 to 0.78)
and B 0.27 (95 % CI -0.36 to 0.90), respectively]. Both
groups showed a slight increase in pain and fatigue over
time. On physical role limitations of the RAND36, both
groups improved slightly, but the difference between the
groups was not significant [B -3.29 (95 % CI -13.92 to
7.34)]. We found no significant intervention effects on
physical functioning and mental health [B -1.69 (95 % CI
-5.91 to 2.53) and B 0.78 (95 % CI -2.91 to 4.46)
respectively]. The intervention group improved in per-
ceived health change, while the control group worsened,
although this difference was also not significant [B 4.89
(95 % CI -1.66 to 11.44)].
Sensitivity Analysis
In the subgroup, we found no statistically significant effect
of the intervention on at-work productivity loss [B 0.39
(95 % CI -0.24 to 1.01)].




We evaluated an intervention program consisting of inte-
grated care and a participatory workplace intervention and
investigated its effectiveness after 12 months of follow-up.
We found no intervention effects on any outcome: at-work
productivity loss, work instability, pain, fatigue, and
quality of life.
Comparison with Other Studies
The intervention we evaluated has been proven effective in
a previous study. Lambeek et al. evaluated the same
intervention for workers with low back pain who were on
sick leave. The median time until sustainable return to
work was 88 days in the intervention group compared to
208 days in the usual care group (p = 0.003) [34]. The
differences between our study and the study of Lambeek
et al. are the study population and the outcome. We did not
include workers who were on sick leave, and focused on
functioning at work instead of return to work. In a situation
where a worker is on sick leave, the need to act is much
higher than was the case in our study, resulting in more
room for improvement. Workers in our study were present
at work, and conducted their normal tasks. This lowers the
necessity for both the worker and supervisor to discuss
barriers at the workplace, resulting in improvements at the
workplace.
If we compare our study to other studies for workers
with RA with a focus on work functioning and sick leave,
we come across either medical, or work-related interven-
tions. An example of a medical study is performed by
Eriksson et al. [35], who analysed the effect of biological
treatment on sick leave. It was shown that the group treated
with a biological had better radiological outcomes, but this
result did not translate into better work outcomes. This
suggests that a purely medical intervention alone is not
enough to improve work participation.
An example of a work-related intervention is described
in a Dutch study in which a multidisciplinary job-retention
vocational rehabilitation program was compared to usual
care [36]. The intervention aimed to guide patients and
adapt an intervention to the specific needs of a patient. At
follow-up, no differences were found between the groups
Fig. 1 Flow diagram Care for
Work study
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on job retention. An important difference with our inter-
vention is that this intervention did not incorporate active
involvement of the workplace (i.e. a work visit, or
involvement of the supervisor). Macedo et al. [37] evalu-
ated an intervention which, a work visit was included,
besides other intervention components. Patients were
included if they had a medium or high work disability risk
according to the RA WIS. The intervention was signifi-
cantly beneficial on work instability, work satisfaction, and
work performance. This strengthens our hypothesis that the
workplace should be included in the intervention to
enhance work-related outcomes in RA patients.
When comparing our study population with the study
population of the Macedo study, they are comparable in
age, disease duration, and the fact that mostly women
participated. The big difference however, is the score of the
study populations on work instability measured with the
RA WIS. The RA WIS leads to a score between 0 and 23
which indicates the disability risk. A higher score indicates
a higher risk. In our study, participants scored on average
between eight and nine points on the RA WIS, which
indicates low risk. If we look at the corresponding risk,
approximately 36–39 % of our participants had a medium
risk at baseline, and between 5 and 12 % a high risk of
work disability. As we drew our study sample from the
general RA population of the participating hospitals, this
sample might have been too stable in its work situation and
too little limited in work functioning. Participants in the
Macedo study had either medium risk (a score between 10
and 17 points) or high risk (a score[17 points) at baseline.
The findings of the Macedo study indicate that participants
with a higher risk for work disability might have more to
Table 1 Baseline
characteristics of the study
population n = 150
Variable Control n = 75 Intervention n = 75
Gendera Male 12 (16 %) 12 (16 %)
Female 63 (84 %) 63 (84 %)
Comorbidity presenta No 24 (32 %) 29 (39 %)
Yes 51 (68 %) 46 (61 %)
Educationa Low 16 (21 %) 16 (21 %)
Middle 26 (35 %) 22 (29 %)
High 33 (44 %) 37 (49 %)
Job satisfactiona Satisfied 57 (76 %) 46 (61 %)
Not satisfied 18 (24 %) 29 (39 %)
Ageb Years 49.6 (8.7) 49.8 (8.6)
HAQb 0–3 0.8 (0.5) 0.8 (0.6)
DAS28b 0– 2.7 (1.2) 2.7 (1.3)
Duration since diagnosisb Years 10.0 (8.6) 10.9 (9.1)
Biological usea No 40 (53 %) 38 (51 %)
Yes 34 (45 %) 36 (48 %)
WLQ lost hoursb Hours 3.4 (2.8)* 4.6 (2.5)*
RAWISb 0–23 7.9 (4.8)* 9.8 (4.6)*
RA WIS corresponding risk Low 44 (59 %) 37 (49 %)
Medium 27 (36 %) 29 (39 %)
High 4 (5 %) 9 (12 %)
RAND physical functioningb 0–100 65.7 (21.0) 68.5 (22.0)
RAND physical role limitationsb 0–100 53.7 (40.4) 42.3 (39.6)
RAND mental healthb 0–100 80.1 (14.4)* 74.4 (14.2)*
RAND perceived health changeb 0–100 51.7 (24.1) 51.7 (29.2)
Co-worker support JCQb 1–4 3.1 (0.5) 3.1 (0.5)
Supervisor support JCQb 1–4 3.0 (0.6) 3.0 (0.6)
Decision authority JCQb 1–4 2.7 (0.5) 2.8 (0.6)
Psychological job demands JCQb 1–4 2.7 (0.3) 2.6 (0.3)
Physical job demands JCQb 1–4 2.0 (0.6) 2.0 (0.6)
* Significant difference p\ 0.05
a n (%)
b m (SD)
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gain from a work-related intervention. This was also
emphasized in the study of Baldwin et al. [38]. They
evaluated a workplace ergonomic intervention carried out
at the workplace. Although they found a significant dif-
ference between groups, i.e. the intervention group repor-
ted less arthritis-related impact on their work. In addition,
they included patients with a mild degree of limitations in
work functioning at baseline, which might explain the
small changes over time they found [38].
Strengths and Limitations
We measured at-work productivity loss with the WLQ.
This is a strength because of the reliability and validity of
the WLQ among workers with RA. However, up till now,
there is no consensus about which questionnaire to use in
order to measure at-work productivity loss. As was shown
by Zhang et al. [33], estimates of at-work productivity loss
vary greatly according to the instrument chosen. In the
Zhang study, 250 workers with either RA or osteoarthritis
were asked to fill out a questionnaire containing four
instruments to measure at-work productivity loss [WLQ,
Health and Labour Questionnaire (HLQ), the World Health
Organization’s Health and Work Performance Question-
naire (HPQ), and the Work Productivity and Activity
Impairment Questionnaire (WPAI)]. The average number
of lost hours per 2 weeks ranged from 1.6 to 14.2 h. This
highlights the variety among instruments to measure at-
work productivity loss. The use of another instrument
might therefore have yielded a different magnitude of at-
work productivity loss. However, as we focussed on group
differences over time, we do not expect differences in the
effects reported in this study.
A study weakness is the potential bias due to the sys-
tematic error in our minimisation procedure, which led to a
difference in the effect estimate of more than 10 %
between analyses on the total group and subgroup. How-
ever, our sensitivity analysis did not lead to a different









B (95 % CI) crudea B (95 % CI) adjustedb
At-work productivity loss Intervention 4.6 (2.5) 4.5 (3.1) 4.6 (3.1) 0.24 (-0.43; 0.90) 0.25 (-0.31; 0.80)
Control 3.4 (2.8) 3.7 (2.5) 3.5 (2.1)
Time management demands
(WLQ)
Intervention 34.8 (24.3) 35.8 (20.4) 35.6 (19.0) 3.82 (-1.43; 9.08) 2.75 (-1.48; 6.99)
Control 29.5 (23.0) 28.6 (18.9) 29.4 (22.8)
Physical demands (WLQ) Intervention 31.0 (20.9) 27.1 (20.2) 31.4 (19.2) -1.48 (-6.60; 3.63) -0.86 (-5.54; 3.82)
Control 26.9 (19.9) 30.0 (21.7) 27.1 (20.7)
Mental-interpersonal demands
(WLQ)
Intervention 24.1 (18.8) 23.2 (19.0) 24.1 (20.4) 1.58 (-2.82; 5.98) 0.78 (-2.85; 4.41)
Control 19.0 (18.4) 19.3 (13.7) 19.1 (17.1)
Output demands (WLQ) Intervention 32.1 (19.6) 29.0 (19.6) 28.9 (19.0) 0.84 (-4.05; 5.74) 0.68 (-3.36; 4.73)
Control 22.2 (18.7) 22.1 (17.4) 22.8 (18.9)
Work instability Intervention 9.8 (4.6) 8.6 (4.6) 9.3 (5.2) -0.29 (-1.41; 0.84) 0.10 (-0.84; 1.05)
Control 7.9 (4.8) 7.9 (5.9) 7.7 (6.0)
Pain Intervention 3.7 (2.5) 3.8 (2.6) 4.1 (2.6) 0.19 (-0.41; 0.78) 0.51 (-0.003; 1.02)
Control 3.7 (2.5) 3.8 (2.4) 3.9 (2.4)
Fatigue Intervention 4.8 (2.5) 5.1 (2.7) 5.6 (2.7) 0.27 (-0.36; 0.90) 0.49 (-0.07; 1.05)
Control 4.4 (2.6) 4.7 (2.7) 5.1 (2.7)
Physical role limitations Intervention 42.3 (39.6) 48.0 (40.5) 44.0 (41.7) -3.29 (-13.92; 7.34) -0.29 (-9.02; 8.44)
Control 53.7 (40.4) 52.1 (42.8) 56.0 (40.2)
Physical functioning Intervention 68.5 (22.0) 70.7 (20.4) 66.0 (20.9) -1.69 (-5.91; 2.53) -2.50 (-5.91; 0.91)
Control 65.7 (21.0) 68.7 (19.4) 69.3 (20.0)
Mental health Intervention 74.3 (14.2) 78.4 (14.0) 75.4 (15.8) 0.78 (-2.91; 4.46) 0.73 (-2.30; 3.78)
Control 80.1 (14.4) 79.8 (15.7) 79.6 (15.7)
Perceived health change Intervention 51.7 (29.2) 53.0 (30.1) 52.8 (23.4) 4.89 (-1.66; 11.44) 3.68 (-2.38; 9.74)
Control 51.7 (24.1) 49.0 (22.6) 46.5 (24.2)
B difference between the groups on average over time, CI confidence interval
a Adjusted for baseline value of the outcome
b Further adjusted for at-work productivity loss, work instability, decision authority, psychological job demands, physical functioning, physical
role limitations, mental health, fatigue, job satisfaction, and comorbidity
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conclusion, as no effects were present in any analysis.
Based on these findings the allocation error did not influ-
ence our conclusions about the effectiveness of our inter-
vention program.
A study weakness is the relatively mild degree of lim-
itations in work functioning (low work instability at base-
line, and little at-work productivity loss). Such low scores
suggest a decreased opportunity to improve work func-
tioning and detect changes. The results are also limited
because our study population consisted of workers with a
mean disease duration of 10 years (which implies a
stable work situation), and the fact that workers could
indicate themselves whether they wanted to participate.
This suggests that workers who did participate, were under
the impression that their supervisor would be supportive of
the intervention [39].
Study Implications
We were not able to find evidence for the effectiveness of a
workplace integrated care intervention for workers with
RA. Nevertheless, workers that are limited in their work
functioning are a relevant target group for future inter-
ventions as sustained employability is an important goal for
society. It is important to support this group in order to
keep them at work, and prevent future work disability. The
target group of a workplace integrated care intervention
should be critically addressed in future studies. Our study
sample consisted of RA patients between 18 and 64 years
with paid work and at least minor limitations at work. For
future studies, we propose to focus on those workers who
are severely limited in their work functioning, and whose
work situation is unstable (i.e. early in the disease course).
We furthermore propose to conduct studies with a longer
follow-up duration.
It is furthermore important to proceed with research on
which method is most accurate in measuring at-work pro-
ductivity loss. As estimates from different measurement
instruments can vary, consensus concerning how to mea-
sure at-work productivity loss should lead to better com-
parability between studies, and better insight into the
magnitude of at-work productivity loss.
Conclusions
The workplace integrated care intervention evaluated in
this study, did not show any effect on the predefined out-
comes at-work productivity, work instability, pain, fatigue
and quality of life. Future research should focus on eval-
uating the intervention in groups of workers with severe
limitations in work functioning and an unstable work
situation.
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